Methotrexate Intolerance in Juvenile Idiopathic Arthritis: Definition, Risks, and Management
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Methotrexate Intolerance in Juvenile Idiopathic Arthritis: Definition, Risks, and Management ; volume:26 ; number:5 ; day:24 ; month:7 ; year:2024 ; pages:479-498 ; date:9.2024
Pediatric drugs ; 26, Heft 5 (24.7.2024), 479-498, 9.2024
- Urheber
-
Wibrand, Camilla
Kyvsgaard, Nini
Herlin, Troels
Glerup, Mia
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40272-024-00643-9
- URN
-
urn:nbn:de:101:1-2411110946427.815872601206
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:21 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Wibrand, Camilla
- Kyvsgaard, Nini
- Herlin, Troels
- Glerup, Mia
- SpringerLink (Online service)
Ähnliche Objekte (12)
Pharmacological conditioning for juvenile idiopathic arthritis: a potential solution to reduce methotrexate intolerance
Mutations in the MTHFR gene are not associated with Methotrexate intolerance in patients with juvenile idiopathic arthritis
Predictors of response to methotrexate in juvenile idiopathic arthritis
Methotrexate intolerance in Rheumatoid Arthritis
Intolerance in oral versus subcutaneous administration of methotrexate in patients with juvenile idiopathic arthritis: a cross-sectional, observational study
Successful treatment of methotrexate intolerance in juvenile idiopathic arthritis using eye movement desensitization and reprocessing – treatment protocol and preliminary results
Methotrexate restores effector T cell responsiveness in juvenile idiopathic arthritis
Predictors of response to methotrexate in juvenile idiopathic arthritis patients
Methotrexate-induced nausea in the treatment of juvenile idiopathic arthritis
High frequency of methotrexate intolerance in longstanding rheumatoid arthritis: using the methotrexate intolerance severity score (MISS)
Reasons for stopping methotrexate treatment in patients with juvenile idiopathic arthritis
Immunomodulatory actions of methotrexate on T cells in juvenile idiopathic arthritis
Pharmacological conditioning for juvenile idiopathic arthritis: a potential solution to reduce methotrexate intolerance
Mutations in the MTHFR gene are not associated with Methotrexate intolerance in patients with juvenile idiopathic arthritis
Predictors of response to methotrexate in juvenile idiopathic arthritis
Methotrexate intolerance in Rheumatoid Arthritis
Intolerance in oral versus subcutaneous administration of methotrexate in patients with juvenile idiopathic arthritis: a cross-sectional, observational study
Successful treatment of methotrexate intolerance in juvenile idiopathic arthritis using eye movement desensitization and reprocessing – treatment protocol and preliminary results
Methotrexate restores effector T cell responsiveness in juvenile idiopathic arthritis
Predictors of response to methotrexate in juvenile idiopathic arthritis patients
Methotrexate-induced nausea in the treatment of juvenile idiopathic arthritis
High frequency of methotrexate intolerance in longstanding rheumatoid arthritis: using the methotrexate intolerance severity score (MISS)
Reasons for stopping methotrexate treatment in patients with juvenile idiopathic arthritis
Immunomodulatory actions of methotrexate on T cells in juvenile idiopathic arthritis
Pharmacological conditioning for juvenile idiopathic arthritis: a potential solution to reduce methotrexate intolerance
Mutations in the MTHFR gene are not associated with Methotrexate intolerance in patients with juvenile idiopathic arthritis
Predictors of response to methotrexate in juvenile idiopathic arthritis
Methotrexate intolerance in Rheumatoid Arthritis
Intolerance in oral versus subcutaneous administration of methotrexate in patients with juvenile idiopathic arthritis: a cross-sectional, observational study
Successful treatment of methotrexate intolerance in juvenile idiopathic arthritis using eye movement desensitization and reprocessing – treatment protocol and preliminary results
Methotrexate restores effector T cell responsiveness in juvenile idiopathic arthritis
Predictors of response to methotrexate in juvenile idiopathic arthritis patients
Methotrexate-induced nausea in the treatment of juvenile idiopathic arthritis
High frequency of methotrexate intolerance in longstanding rheumatoid arthritis: using the methotrexate intolerance severity score (MISS)
Reasons for stopping methotrexate treatment in patients with juvenile idiopathic arthritis